Israeli pharma-tech company Syqe Medical recently conducted a clinical trial in which they found evidence that inhaling “extremely low and precise doses” of tetrahydrocannabinol (THC) – the principal psychoactive component in cannabis products – can be used as an effective pain reliever while avoiding the “common [psychoactive] side effects” normally associated with cannabis use.

Read more here.